IBB vs VIG
iShares Biotechnology ETF vs Vanguard Dividend Appreciation ETF
- • VIG has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • VIG pays a higher dividend yield (1.47%).
Side-by-side metrics
| Metric | IBB | VIG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.16% | 1.47% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $135.70B |
YTD return | 30.22% | 14.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.70 |
P/E ratio | 25.48 | 26.31 |
Last price | $217.75 | $251.63 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
VIG top holdings
| MSFT | Microsoft Corp | 4.91% |
| AAPL | Apple Inc | 4.89% |
| AVGO | Broadcom Inc | 4.30% |
| LLY | Eli Lilly and Co | 4.10% |
| JPM | JPMorgan Chase & Co | 3.90% |
| XOM | ExxonMobil Holdings Corp | 2.97% |
| JNJ | Johnson & Johnson | 2.83% |
| V | Visa Inc Class A | 2.53% |
| WMT | Walmart Inc | 2.05% |
| ABBV | AbbVie Inc | 2.05% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $135.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.47%. Its largest holding is Microsoft Corp (MSFT), which represents 4.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 3.9%.